Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.7 |